WARRINGTON, Pa., March 8, 2021 /PRNewswire/ -- Windtree
Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical
device company focused on advancing multiple late-stage
interventions for acute cardiovascular and pulmonary disorders,
today announced that Craig Fraser,
president and chief executive officer, will present at the H.C.
Wainwright Global Life Sciences Conference and be available for 1x1
meetings. Details are as follows:
H.C. Wainwright
Global Life Sciences Conference
|
|
Date:
|
March 9-10,
2021
|
Time:
|
available for 1x1
meetings
|
Webcast:
|
To register, click on
the link HERE
|
A live audio webcast will be available via the events page of
the Windtree website at http://windtreetx.investorroom.com/events.
A replay of the presentation will be archived on the Windtree
website for 30 days for those unable to listen live.
About Windtree Therapeutics
Windtree Therapeutics,
Inc. is advancing multiple late-stage interventions for acute
cardiovascular and pulmonary disorders to treat patients in moments
of crisis. Using new clinical approaches, Windtree is developing a
multi-asset franchise anchored around compounds with an ability to
activate SERCA2a, with lead candidate istaroxime being developed as
a first-in-class treatment for acute heart failure and early
cardiogenic shock in heart failure. Windtree has also focused on
developing AEROSURF® as a non-invasive surfactant treatment for
premature infants with respiratory distress syndrome, and is
facilitating transfer of clinical development of AEROSURF® to
its licensee in Asia, Lee's HK, while Windtree evaluates
other uses for its synthetic KL4 surfactant for the treatment of
acute pulmonary conditions including lung injury due to viral,
chemical and radiation induced insults. Also, in its portfolio is
rostafuroxin, a novel precision drug product targeting hypertensive
patients with certain genetic profiles.
For more information, please visit the Company's website
at www.windtreetx.com.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/windtree-to-present-at-the-hc-wainwright-global-life-sciences-conference-301241442.html
SOURCE Windtree Therapeutics, Inc.